Brain Imaging Modalities Market Report 2026

Brain Imaging Modalities Market Overview

• Brain Imaging Modalities market size has reached to $13.9 billion in 2025 • Expected to grow to $18.55 billion in 2030 at a compound annual growth rate (CAGR) of 5.9% • Growth Driver: Rising Neurological Disorders Fuels Growth In Brain Imaging Modalities Market • Market Trend: nnovative Solutions For Enhanced Brain Imaging And Diagnostics • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Brain Imaging Modalities Market?

Brain imaging modalities are techniques used to visualize the brain's structure, function, and activity, assisting doctors and researchers in diagnosing and understanding brain-related conditions. These methods help identify brain issues, study brain function, and support doctors in treatment planning. The main product types of brain imaging modalities are devices, accessories, and usability. Brain imaging devices are sophisticated machines designed to capture detailed images or functional data of the brain. The imaging types are computed tomography (CT), positron emission tomography (PET), magnetic resonance imaging (MRI), and single photon emission computed tomography (SPECT), and the modalities include stand-alone functional brain imaging systems and portable functional brain imaging systems. The patients are adults, pediatrics, and infants, and it is used by various end-users such as hospitals, diagnostic centers, and research institutes.

What Is The Brain Imaging Modalities Market Growth Forecast?

The brain imaging modalities market size is expected to see strong growth in the next few years. It will grow to $18.55 billion in 2030 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to technological advancements in fMRI and PET systems, rising adoption of portable and research-oriented imaging devices, growing investment in neuroimaging research, increasing integration of ai and big data analytics, expansion of hospitals and diagnostic facilities. Major trends in the forecast period include rising adoption of advanced mri and ct imaging techniques, increasing use of portable and point-of-care brain imaging systems, growing demand for pediatric and infant brain imaging solutions, integration of image processing software and patient monitoring systems, expansion of functional brain imaging for research and clinical applications.

Global Brain Imaging Modalities Market Segmentation

1) By Product: Devices, Accessories, Usability 2) By Imaging Type: Computed Tomography (CT), Positron Emission Tomography (PET), Magnetic Resonance Imaging (MRI), Single Photon Emission Computed Tomography (SPECT) 3) By Modalities: Stand-Alone Functional Brain Imaging Systems, Portable Functional Brain Imaging Systems 4) By Patient Type: Adults, Pediatrics, Infants 5) By End-User: Hospitals, Diagnostic Centers, Research Institutes Subsegments: 1) By Devices: Magnetic Resonance Imaging (MRI) Machines, Computed Tomography (CT) Scanners, Positron Emission Tomography (PET) Scanners, Electroencephalography (EEG) Devices, Functional MRI (fMRI) Systems, Single Photon Emission Computed Tomography (SPECT) Scanners 2) By Accessories: Contrast Agents, MRI Coils, EEG Electrodes, Image Processing Software, Patient Monitoring Systems 3) By Usability: Portable Brain Imaging Devices, Stationary Brain Imaging Systems, Point-Of-Care Brain Imaging Solutions, Research-Oriented Brain Imaging Equipment

What Is The Driver Of The Brain Imaging Modalities Market?

The increasing prevalence of neurological disorders is expected to propel the growth of the brain imaging modality market going forward. Neurological disorders refer to medical conditions that affect the nervous system, including the brain, spinal cord, and nerves, resulting in problems with movement, sensation, cognition, or behavior. Neurological disorders are increasing due to factors such as an aging population, better diagnosis, chronic diseases, genetic factors, improved diagnostics, environmental changes, and lifestyle factors. Brain imaging modalities are used to diagnose and monitor neurological disorders by providing detailed images of the brain's structure and function, aiding in effective treatment planning. For instance, in January 2025, according to the European Brain Council, a Belgium-based non-profit organization, 7 million people in Europe are living with Alzheimer’s disease, with estimates suggesting this number is projected to rise to a staggering 14 million by 2030. Therefore, the increasing prevalence of neurological disorders is driving the growth of the brain imaging modality market.

Key Players In The Global Brain Imaging Modalities Market

Major companies operating in the brain imaging modalities market are Hitachi Ltd, Siemens AG, Toshiba Corporation, FUJIFILM Corporation, Koninklijke Philips N.V, GE HealthCare Technologies Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Shimadzu Corporation, Canon Medical Systems Corporation, Neusoft Corporation, Agfa-Gevaert N.V., Carestream Health, Brainlab AG, Esaote SpA, NeuroLogica Corp., Swissray International Inc., Xoran Technologies LLC., Allengers Medical Systems Ltd., Konica Minolta Healthcare Americas Inc., Hi-Tech Medical Imaging

Global Brain Imaging Modalities Market Trends and Insights

Major companies operating in the brain imaging modalities market are focusing on developing innovative technologies, such as neuroimaging technologies, to gain a competitive advantage. Neuroimaging technologies are advanced medical tools used to capture detailed images of the brain's structure and function. For instance, in February 2024, Koninklijke Philips N.V., a Netherlands-based technology company, partnered with SyntheticMR, a Sweden-based software company, to launch Smart Quant Neuro 3D, which features automated 3D quantification of neuroimaging data, real-time visualization of brain structures, and integration with artificial intelligence for improved diagnostic accuracy. This innovation aims to streamline workflows and reduce the time required for image analysis, ultimately benefiting healthcare providers and patients alike.

What Are Latest Mergers And Acquisitions In The Brain Imaging Modalities Market?

In April 2023, GE HealthCare Technologies Inc., a US-based medical technology company acquired IMACTIS for an undisclosed amount. This acquisition aims to enhance its technological capabilities in the healthcare sector by incorporating IMACTIS's innovative navigation solutions. IMACTIS is a US-based company specializing in computer-assisted interventional radiology.

Regional Outlook

North America was the largest region in the brain imaging modalities market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Brain Imaging Modalities Market?

The brain imaging modalities market consists of sales of structural magnetic resonance imaging (MRI), high-resolution computed tomography (CT), and functional near-infrared spectroscopy (fNIRS). Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.